AstraZeneca PLC (AZN)
AstraZeneca PLC Net Debt to Free Cash Flow
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Debt to Free Cash Flow | (0.9x) | (0.9x) | (1.0x) | 1.6x | 1.6x | (0.0x) | (0.4x) | (0.4x) | 0.8x | 0.1x | 0.9x | 15.3x | 7.1x | 7.7x | 12.3x | 27.9x | 6.7x | 7.2x | 3.4x | 3.5x |
AstraZeneca PLC (AZN) Net Debt to Free Cash Flow comparison analysis
AZN key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
FAQ
1) What is AstraZeneca PLC's Net Debt to Free Cash Flow?
As of today, Microsoft Corp's last 12-month Net Debt to Free Cash Flow is 3.4x, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Net Debt to Free Cash Flow for AstraZeneca PLC have been 4.4x over the past three years, and 6.7x over the past five years.
2) Is AstraZeneca PLC's Net Debt to Free Cash Flow Good?
As of today, AstraZeneca PLC's Net Debt to Free Cash Flow is 3.4x, which is higher than industry median of 1.3x. It indicates that AstraZeneca PLC's Net Debt to Free Cash Flow is Bad.